Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients.
Akalin
Enver
E
Ames
Scott
S
Sehgal
Vinita
V
Murphy
Barbara
B
Bromberg
Jonathan S
JS
Fotino
Marilena
M
Friedlander
Rex
R
D000961:Antilymphocyte Serum / Q000276:immunology* / Q000627:therapeutic use; D004198:Disease Susceptibility; D005260:Female; D006084:Graft Rejection / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology* / Q000627:therapeutic use*; D007167:Immunotherapy; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D014180:Transplantation
D000961:Antilymphocyte Serum; D016756:Immunoglobulins, Intravenous